.jpg)
| |||||||||
|
|||||||||
|
By:
The Star | |||||||||
| Posted:
Oct,20-2021 13:52:13
| |||||||||
|
Kenya has established a new company to start vaccine production in Nairobi's Embakasi area by Easter next year.
President Uhuru Kenyatta said the company will be known as the Kenya Biovax Limited.
“The Ministry of health should operationalise this company to eventually manufacture vaccines in our country by Easter next year,” he said.
He said the pandemic had exposed the lack of manufacturing facilities both in Kenya and other African countries.
The facility is expected to be a fill-and-finish factory ahead of the country setting up a full-scale manufacturing plant to guarantee supply.
Such fill-and-finish facilities allow third parties to construct ready-made vaccines into vials, package them for sale.
The country aims to have a fully fledged human vaccine manufacturing capability by 2024, the National Covid-19 Vaccine Deployment Plan from the Ministry of Health shows.
The facility will be built at the former Kemsa depot in Embakasi, according to MoH.
It will also produce other vaccines, such as the polio drops.
Vaccine ingredients will be imported in bulk. At the new plant, the vaccines will be produced, sealed in vials, labelled and finished.
| |||||||||
|
Source:
The Star
| |||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RSS